Clough Capital Partners L P Cuts Position in UnitedHealth Group Incorporated $UNH

Key Points

• Clough Capital Partners L P trimmed its UnitedHealth stake by 80.2% in Q3, selling 77,581 shares and leaving 19,210 shares valued at about $6.63 million, while institutional investors own roughly 87.86% of UNH.
• UnitedHealth slightly beat quarterly expectations with EPS of $2.11 (vs. $2.09) and revenue of $113.73 billion (+12.3% YoY), set FY2026 guidance near 17.75 EPS, and has a consensus analyst target around $372 with a "Moderate Buy" rating.
• The company declared a quarterly dividend of $2.21 per share (annualized $8.84, ~3.1% yield) payable March 17 (ex-dividend March 9), and the stock has shown wide volatility—trading between $234.60 and $606.36 over the past year with commentary noting a ~39% 12‑month decline.

Clough Capital Partners L P trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 80.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,210 shares of the healthcare conglomerate's stock after selling 77,581 shares during the period. Clough Capital Partners L P's holdings in UnitedHealth Group were worth $6,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. North Capital Inc. grew its stake in shares of UnitedHealth Group by 16.2% in the 3rd quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate's stock worth $67,000 after buying an additional 27 shares in the last quarter. Sunflower Bank N.A. lifted its holdings in shares of UnitedHealth Group by 1.5% in the 3rd quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate's stock valued at $662,000 after acquiring an additional 28 shares during the last quarter. Axis Wealth Partners LLC increased its stake in UnitedHealth Group by 1.7% during the third quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate's stock worth $563,000 after acquiring an additional 28 shares during the last quarter. Abound Wealth Management lifted its stake in shares of UnitedHealth Group by 13.5% in the 3rd quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate's stock valued at $84,000 after purchasing an additional 29 shares during the last quarter. Finally, Auxano Advisors LLC increased its position in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Auxano Advisors LLC now owns 964 shares of the healthcare conglomerate's stock valued at $333,000 after purchasing an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $282.02 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a market cap of $255.99 billion, a price-to-earnings ratio of 21.38, a price-to-earnings-growth ratio of 1.30 and a beta of 0.41. The firm has a 50-day moving average of $303.36 and a two-hundred day moving average of $325.11. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same period last year, the company posted $6.81 earnings per share. The company's quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group's dividend payout ratio is presently 67.02%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. UBS Group lowered their price target on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a research report on Wednesday, January 28th. Piper Sandler restated an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating on the stock in a report on Friday, January 23rd. Truist Financial dropped their target price on UnitedHealth Group from $410.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, February 2nd. Finally, Evercore upgraded UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $372.13.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Sen. Markwayne Mullin disclosed a purchase of $50k–$100k in UNH shares, a small institutional/insider-like buy that can be read as a signal of confidence and may attract retail/institutional attention. Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Here's What He Bought And Sold
• Positive Sentiment: Short-term price resilience: coverage noted UNH advancing while broader markets declined recently, a sign of relative strength that can draw momentum buyers. UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
• Neutral Sentiment: High investor attention: Zacks and Yahoo pieces highlight UNH as a heavily searched/watched stock; increased attention can boost liquidity and volatility but is not a directional catalyst by itself. UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: Investor materials: a Barclays healthcare conference transcript was published; investors will parse management commentary for membership trends, margin drivers, and capital allocation but no surprise datapoint was flagged in headlines. UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
• Neutral Sentiment: Analyst coverage and model updates continue to circulate (stock-forecast pieces), which keep expectations and target-price dispersion visible to the market but provide mixed near-term directional pressure. UnitedHealth Group Incorporated (UNH) Stock Forecasts
• Negative Sentiment: Valuation/sector pressure concerns: commentary noting a ~39% 12‑month share decline and questioning whether current price reflects value could pressure sentiment and keep selling pressure if investors worry about sector headwinds or earnings risk. Is UnitedHealth Group (UNH) Pricing Reflect Sector Pressures After A 39% Share Price Decline

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.